PTX vs SPL

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

PTX

PRESCIENT FPO [PTX]

58MEDIUM

SPL

STARPHARMA FPO [SPL]

58MEDIUM

Score Breakdown

PTX SPL
Technical
83
72
Catalyst
53
58
Sentiment
50
50
Fundamental
53
80
Momentum
75
80
Risk Gate
50
50

Key Metrics

PTX Metric SPL
$78.9MMarket Cap$315.7M
886KAvg Volume (20d)794K
N/AShort Interest+0.1%
$0.12552-Week High$0.790
$0.04052-Week Low$0.094
+5.3%Daily Change+5.1%
$0.079Entry Price$0.767
-54.3%ROE-14.5%
-207.7%Profit Margin-22.2%

Active Signals

PTX Signals

MACD momentum is picking up steam
Trading above both moving averages — the trend is your friend here
On a tear — up 11.3% over the last 5 days
Beating the Small Ords index — relative strength of 1.31, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Adequate cash runway (5 quarters)
4C filed 2026-04-29
Revenue declining (-7%)

SPL Signals

MACD momentum is picking up steam
Pressing against the upper Bollinger Band — extended and may need to cool off
Trading above both moving averages — the trend is your friend here
Watch out — volume is flowing out even as price holds up. Distribution pattern
Knocking on the door of resistance — if it punches through, things could get interesting
Beating the Small Ords index — relative strength of 1.18, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Strong cash runway (86 quarters)

Ask Scout AI to compare PTX and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
PTX Full Analysis → SPL Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).